Microbix Assisting EMQN with Novel Genetic-Test EQA Program
For Rapid Identification of Patients Susceptible to Antibiotic-Induced Hearing Loss MISSISSAUGA, CANADA & MANCHESTER, UK – December 10, 2024 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, and EMQN CIC (EMQN), a global supplier of laboratory external quality assessment (“EQA”) schemes for human genomic testing, announce the go-live […]
Webinar: Run 13 Variant Classification External Quality Assessment Summary
Broadcast live on Wednesday 27th November 2024, 13:00 – 14:30 GMT (14:00 – 15:30 CET). Who is it for? Clinical scientists, molecular pathologies, and EQA scheme participants. Agenda: Welcome and introduction to Masterclass and EQA Run 13 Overview of the results from the practical exercise (GENie BRCA/HRR Competency Assessment – Run 13) In depth explanation of Run 13 variant classifications Live Q&A session Summary and close Chairs: Dr. Simon […]
EMQN launches new EQA scheme for MT-RNR1 Point-of-Care Testing (POCT) for use with the Genedrive® MT-RNR1 ID Kit
EMQN CIC is pleased to announce the launch of a new EQA scheme for MT-RNR1 Point-of-Care Testing (POCT), suitable for use with the NICE-approved Genedrive® MT-RNR1 ID Kit. This scheme is designed to support the accurate identification of patients in acute clinical settings who carry the MT-RNR1 m.1555A>G variant, ensuring they receive alternative antibiotics to prevent hearing loss. This […]
“EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancer” endorsed by ERN GENTURIS
EMQN is honoured that ERN GENTURIS has decided to endorse our best practice guidelines: “EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancer (HBOC).” ERN GENTURIS is the European Reference Network (ERN) for all patients with rare genetic tumour risk syndromes. A team of assessors, consisting of HBOC experts and an […]
EMQN CIC partners with Informed Genomics to validate clinical laboratory results
24 September 2024, Birmingham & Manchester, UK – Informed Genomics, the UK-based genomic testing laboratory delivering innovative ISO accredited services, has been selected by EMQN CIC to provide tumour profiling services to support their quality assurance services. Informed Genomics offers comprehensive next-generation sequencing (NGS) cancer mutation analyses from solid tumour and cell-free DNA in a […]
The new 2025 catalogue is now available!
We are proud to present to you the new EQA schemes for 2025, allowing more flexibility, time and cost efficiency, ease of purchase, and more. Our goal is to ensure the highest genomic diagnostic quality from lab to patient, and our updated schemes will help you get there, tailoring our services to your needs. Some of […]
